Meng‐Qiu Li

1.1k citations
15 papers · 423 indexed · h-index 8
Topics
Cancer-related molecular mechanisms research (3 papers)Liver Disease Diagnosis and Treatment (2 papers)Colorectal Cancer Treatments and Studies (2 papers)
Partner nations
China

In The Last Decade

Meng‐Qiu Li

15 papers receiving 419 citations

Peers

Meng‐Qiu Li
Comparison fields: 5 of 75
  • Molecular Biology 249
  • Cancer Research 204
  • Epidemiology 58
  • Endocrinology, Diabetes and Metabolism 39
  • Pathology and Forensic Medicine 38
Replace Mu-Hsin Chang with:
Mu-Hsin Chang Taiwan
Tatiana Bédarida France
Fatemeh Dashti Iran
Beth Griesel United States
Navid Abedpoor Iran
Francisca M. Santandreu Spain
Chuanshi Xiao China
Meng‐Qiu Li relative to Mu-Hsin Chang Taiwan Mu-Hsin Chang's profile →
Citations per field
00.5×5.9×
Mu-Hsin Chang · 1×
Citations per year

Countries citing papers authored by Meng‐Qiu Li

Since Specialization
Citations

This map shows the geographic impact of Meng‐Qiu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Qiu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Qiu Li more than expected).

Fields of papers citing papers by Meng‐Qiu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Qiu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Qiu Li. The network helps show where Meng‐Qiu Li may publish in the future.

Co-authorship network of co-authors of Meng‐Qiu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Qiu Li. A scholar is included among the top collaborators of Meng‐Qiu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Qiu Li. Meng‐Qiu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 7
3 6
4 18
5 9
6
Impact of serum omentin-1 levels on functional prognosis in nondiabetic patients with ischemic stroke.
15
7 4
8 85
9 120
10 16
11 7
12 42
13 1
14 3
15 89

About Meng‐Qiu Li

Meng‐Qiu Li is a scholar working on Clinical Biochemistry, Cancer Research and Reproductive Medicine, having authored 15 papers that have together received 423 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (204 citations), Biochemistry (27 citations) and Molecular Biology (249 citations). Meng‐Qiu Li has collaborated with scholars based in China. Frequent co-authors include Yuan‐Lin Zheng, Jun Lü, Zi-Feng Zhang, Shao‐Hua Fan, Yong‐Jian Wang, Xin‐Rui Han, Min Shen, Qun Shan, Bin Hu and Xin Wen. Their work appears in journals such as Molecular and Cellular Biology, Journal of Bone and Mineral Research and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026